| 1 |
26986978 | Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection. | 2017 Aug |
1 |
| 2 |
26170630 | Selective use of vandetanib in the treatment of thyroid cancer. | 2015 |
1 |
| 3 |
22258476 | Combining the multitargeted tyrosine kinase inhibitor vandetanib with the antiestrogen fulvestrant enhances its antitumor effect in non-small cell lung cancer. | 2012 Mar |
2 |
| 4 |
22343387 | Recent advances in the molecular pathogenesis and targeted therapies of medullary thyroid carcinoma. | 2012 May |
2 |
| 5 |
18687659 | Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib. | 2008 Aug |
1 |